ASCO 2023: Breast Cancer Research Presented by Paolo Tarantino, MD
Dana-Farber
June 21, 2023
Data from more than 8,000 patients with stage 1A triple-negative breast cancer finds improved 5-year breast-cancer specific survival in those treated with adjuvant chemotherapy whose tumors measured between 1-2 cm.